Search clinical trials for: Her2 -
Total 2794 results
-
GE HealthcareLaboratory Corporation of AmericaNot yet recruiting
-
M.D. Anderson Cancer CenterZymeworks BC Inc.Active, not recruitingBreast Cancer | HER2-positiveUnited States
-
Rawalpindi Medical CollegeCompleted
-
The Netherlands Cancer InstituteCompletedBreast Cancer | HER2 PositiveNetherlands
-
RemeGen Co., Ltd.Completed
-
Nippon Kayaku Co., Ltd.CompletedTriple Negative Breast CancerUnited States
-
SUNHO（China）BioPharmaceutical CO., Ltd.RecruitingAdvanced Solid TumorChina
-
AstraZenecaQuintiles; University of Tubingen - GermanyCompletedBreast CancerUnited States, Bulgaria, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Canada, Poland, Australia, Hungary, Taiwan, Japan, Germany, United Kingdom
-
Guangdong Academy of Medical SciencesGuangzhou First People's Hospital; Guangzhou General Hospital of Guangzhou... and other collaboratorsUnknownHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastChina
-
Fudan UniversityHoffmann-La RocheUnknown
-
Anbogen Therapeutics, Inc.RecruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | HER2 MutationsTaiwan
-
Alliance Foundation Trials, LLC.Pfizer; Breast International Group; NSABP Foundation Inc; Austrian Breast & Colorectal... and other collaboratorsActive, not recruitingBreast CancerUnited States, Spain, Italy, Ireland, United Kingdom, Australia, Germany, Japan, Portugal, Taiwan, Canada, Israel, Netherlands, Switzerland, Belgium, Austria, Hungary, Korea, Republic of, Mexico, Poland, Sweden
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedHER2-positive Metastatic Breast CancerChina
-
Baylor Breast Care CenterGlaxoSmithKlineCompleted
-
Shanghai Zhongshan HospitalCompleted
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast AdenocarcinomaUnited States
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedHER2-positive Breast CancerChina
-
Latin American Cooperative Oncology GroupRoche Pharma AG; OncoclínicasNot yet recruitingBreast Cancer | HER2-positive Breast CancerBrazil
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.RecruitingA Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the BrainMetastatic Breast CancerUnited States
-
RemeGen Co., Ltd.RecruitingAdvanced Melanoma | Melanoma, Stage II | HER2-positiveChina
-
UNC Lineberger Comprehensive Cancer CenterIncyte CorporationWithdrawnBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | HER2-positive Breast Cancer
-
Peking University Cancer Hospital & InstituteNot yet recruitingHER2-positive Colorectal Cancer | HER2-positive Biliary Tract CancerChina
-
Seagen Inc.RemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Triple Negative Breast Neoplasms | Gastroesophageal Junction Adenocarcinoma | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States, Canada
-
Michael Morse, MDGlaxoSmithKlineCompletedMetastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingSalivary Gland Cancer | HER2 Gene MutationUnited States
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
National Cancer Institute, NaplesCompletedMetastatic Breast Cancer
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingNon-small Cell Lung CancerChina
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedBreast CancerUnited States
-
Beijing Mabworks Biotech Co., Ltd.RecruitingHER2-positive Recurrent or Metastatic Malignant Solid TumorChina
-
Dana-Farber Cancer InstituteNovartisCompleted
-
Applied Spectral Imaging Ltd.CompletedBreast CancerUnited States, Israel
-
Elevar TherapeuticsTerminatedAdenoid Cystic CarcinomaUnited States, Korea, Republic of
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States, Canada, Finland, France, Italy, Spain, Taiwan, United Kingdom
-
UNICANCERActive, not recruiting
-
Borstkanker Onderzoek GroepRoche Pharma AG; BOOG Study CenterActive, not recruiting
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingHER2 Positive Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7United States
-
Henan Cancer HospitalRecruitingHER2 Low Breast CarcinomaChina
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | HER2-positive Breast Cancer | Advanced Breast Carcinoma | HER2-Positive Breast CarcinomaUnited States
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerSouth Africa, France, Italy, Taiwan, Hungary, Belgium, Spain, Austria, Netherlands, Poland, Russian Federation, United States, Argentina, Brazil, Peru
-
RemeGen Co., Ltd.RecruitingGynecological MalignancyChina
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu Hengrui Pharmaceuticals Co.,LtdNot yet recruitingBreast Cancer | HR+/HER2- Breast Cancer
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruiting
-
University of Illinois at ChicagoRecruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingHER2-positive Breast CancerChina
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingProtocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) (PHARE-C)HER2-positive Breast Cancer